Lysins: the arrival of pathogen-directed anti-infectivesPASTAGIA, Mina; SCHUCH, Raymond; FISCHETTI, Vincent A et al.Journal of medical microbiology. 2013, Vol 62, Num 10, pp 1506-1516, issn 0022-2615, 11 p.Article

Cleavage activity of the sapovirus 3C-like protease in Escherichia coliOKA, T; KATAYAMA, K; OGAWA, S et al.Archives of virology. 2005, Vol 150, Num 12, pp 2539-2548, issn 0304-8608, 10 p.Article

Matrix metalloproteinases in reproductive endocrinologySHAH, Bukhtiar H; CATT, Kevin J.Trends in endocrinology and metabolism. 2004, Vol 15, Num 2, pp 47-49, issn 1043-2760, 3 p.Article

HIGH RESOLUTION IN SITU ZYMOGRAPHY REVEALS MATRIX METALLOPROTEINASE ACTIVITY AT GLUTAMATERGIC SYNAPSESGAWLAK, M; GORKIEWICZ, T; GORLEWICZ, A et al.Neuroscience. 2009, Vol 158, Num 1, pp 167-176, issn 0306-4522, 10 p.Article

Pharmacology and immunology of botulinum neurotoxinsAOKI, K. Roger.International ophthalmology clinics. 2005, Vol 45, Num 3, pp 25-37, issn 0020-8167, 13 p.Article

Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinaseNAKAMURA, Hiroyuki; SUENAGA, Naoko; TANIWAKI, Kaori et al.Cancer research (Baltimore). 2004, Vol 64, Num 3, pp 876-882, issn 0008-5472, 7 p.Article

Dispensable PDZ domain of Escherichia coli YaeL essential proteaseBOHN, Chantal; COLLIER, Justine; BOULOC, Philippe et al.Molecular microbiology (Print). 2004, Vol 52, Num 2, pp 427-435, issn 0950-382X, 9 p.Article

Matrix metalloproteinases and matrikines in angiogenesisBELLON, Georges; MARTINY, Laurent; ROBINET, Arnaud et al.Critical reviews in oncology/hematology. 2004, Vol 49, Num 3, pp 203-220, issn 1040-8428, 18 p.Article

Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the Asn¹⁰⁹-Tyr bondJING NIE; DUANQING PEI.Cancer research (Baltimore). 2003, Vol 63, Num 20, pp 6758-6762, issn 0008-5472, 5 p.Article

Complications with the use of botulinum toxinKLEIN, Arnold William.International ophthalmology clinics. 2005, Vol 45, Num 3, pp 163-169, issn 0020-8167, 7 p.Article

Cosmetic botulinum neurotoxin applicationKHAN, Jemshed A.International ophthalmology clinics. 2005, Vol 45, Num 3, pp 107-122, issn 0020-8167, 16 p.Article

Practical aspects of cosmetic botulinum toxinMANNOR, Geva E.International ophthalmology clinics. 2005, Vol 45, Num 3, pp 99-106, issn 0020-8167, 8 p.Article

Modifying brow position with botulinum toxinFOSTER, Jill A; PROFFER, Paul L; PROFFER, Liana H et al.International ophthalmology clinics. 2005, Vol 45, Num 3, pp 123-131, issn 0020-8167, 9 p.Article

Une toxine botulique de type A modulaire et non pathogène = A modular and non pathogenic type A botulinum toxinDARIOS, Frédéric.MS. Médecine sciences. 2011, Vol 27, Num 8-9, pp 694-696, issn 0767-0974, 3 p.Article

Sequence features of substrates required for cleavage by GlpG, an Escherichia coli rhomboid proteaseAKIYAMA, Yoshinori; MAEGAWA, Saki.Molecular microbiology (Print). 2007, Vol 64, Num 4, pp 1028-1037, issn 0950-382X, 10 p.Article

Actualités sur l'utilisation de la toxine botuliqueLAFARGE CLAOUE, Béatrice.La Revue de chirurgie esthétique de langue française. 2004, Vol 28, Num 114, pp 22-26, issn 0336-7525, 5 p.Article

Long-term effects of Botulinum toxin on neuromuscular functionFRICK, Christiane G; RICHTSFELD, Martina; SAHANI, Nita D et al.Anesthesiology (Philadelphia). 2007, Vol 106, Num 6, pp 1139-1146, issn 0003-3022, 8 p.Article

Botulinum toxin for pain management and other medical conditions: a comprehensive reviewARGOFF, Charles E.The Clinical journal of pain. 2002, Vol 18, Num 6, issn 0749-8047, 90 p., SUPSerial Issue

Indications actuelles de la toxine botuliqueSANGLA, Sophie; PATTE-KARSENTI, Nathalie.La Revue du praticien. Médecine générale. 2007, Num 770-771, pp 491-492, issn 0989-2737, 2 p.Article

The cosmetic use of botulinum toxin type BSADICK, Neil; SORHAINDO, Lian.International ophthalmology clinics. 2005, Vol 45, Num 3, pp 153-161, issn 0020-8167, 9 p.Article

An ELISA method to measure total and specific human secretory IgA subclasses based on selective degradation by IgA1-proteaseHOCINI, H; ISCAKI, S; BOUVET, J.-P et al.Journal of immunological methods. 2000, Vol 235, Num 1-2, pp 53-60, issn 0022-1759Article

A method for titration of inhibiting antibodies to bacterial immunoglobulin A1 proteases in human serum and secretionsREINHOLDT, J.Journal of immunological methods. 1996, Vol 191, Num 1, pp 39-48, issn 0022-1759Article

An investigation into the influences of species and biotype on the type of IgA1 protease produced by isolates of HaemophilusSENIOR, B. W; IP, C. L.Journal of medical microbiology. 1999, Vol 48, Num 4, pp 389-394, issn 0022-2615Article

Molecular biology and vaccine aspects of bacterial immunoglobulin A1 proteasesLOMHOLT, Hans.APMIS. Acta pathologica, microbiologica et immunologica scandinavica. Supplementum. 1996, Vol 104, Num 62, issn 0903-465X, 28 p.Thesis

Bacterial immunoglobulin A₁ proteasesMULKS, M. H; SHOBERG, R. J.Methods in enzymology. 1994, Vol 235, pp 543-554, issn 0076-6879Article